Andrea Goren - 05 Oct 2021 Form 4 Insider Report for INVO Bioscience, Inc. (IVF)

Role
Chief Financial Officer
Signature
/s/ Andrea Goren
Issuer symbol
IVF
Transactions as of
05 Oct 2021
Net transactions value
+$99,997
Form type
4
Filing time
07 Oct 2021, 16:57:57 UTC
Previous filing
21 Jun 2021
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Purchase $99,997 +30,674 +67% $3.26 76,383 05 Oct 2021 Via Andax LLC
holding INVO Common Stock 12,500 05 Oct 2021 Direct
holding INVO Common Stock 5,000 05 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units which vest in substantially equal monthly increments over a period of 12 months from the date of grant of June 14, 2021.